Quarterly report [Sections 13 or 15(d)]

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.25.2
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Total net revenue $ 15,009 $ 14,855 $ 28,148 $ 27,885
Other revenue 1,404   1,404  
Net revenue 16,413 14,896 29,552 27,926
Related Party        
Revenue - related party   41   41
Other revenue 1,404   1,404  
Emrosi        
Total net revenue 2,795   4,865  
Qbrexza        
Total net revenue 6,949 6,836 12,110 11,853
Accutane        
Total net revenue 3,395 5,719 7,050 11,538
Amzeeq        
Total net revenue 879 1,205 1,979 1,960
Zilxi        
Total net revenue 256 369 682 642
Other / legacy product revenue        
Total net revenue $ 735 $ 726 $ 1,462 $ 1,892